Tip · Stress & mind

Nootropics starter stack

Caffeine + L-theanine 1:2 as a safe entry point – if desired with lion’s mane for long-term BDNF.

Caffeine plus L-theanine is the usual entry point into nootropics, often extended with alpha-GPC or citicoline and lion’s mane. The first part is measurable and has been assessed by the authorities; the second runs ahead of the data. This page sorts out what the meta-analyses show and where EFSA and BfR draw the limits. Amounts are given here only where they come from an official source.

In short

The robust part of the stack is caffeine, the second best L-theanine. In the meta-analysis on the combination, accuracy improved compared with placebo in the digit vigilance test with SMD = 0.20 and in the attention switching test with SMD = 0.33, each in the second hour after intake. L-theanine alone improved choice reaction time with SMD = 0.51 in 31 randomized trials with 1,168 participants. The claimed synergy, by contrast, was explicitly not recognized by EFSA: it attributes the effect on attention to caffeine. For citicoline, EFSA rejected the memory claim; for alpha-GPC there is only a safety assessment; and the stack as a whole has never been studied.

What is behind it

Caffeine blocks adenosine receptors. Adenosine accumulates during wakefulness and dampens the excitability of nerve cells; when it is displaced, central nervous activation increases. This explains both the desired effect, that is, more alertness and better attention, and the undesired one, that is, nervousness, restlessness and increased heart rate. The BfR describes the effect as stimulation of the cardiovascular and central nervous systems with a possible increase in concentration and physical performance.

L-theanine is a non-proteinogenic amino acid from the leaves of the tea plant. The logic of the combination is: L-theanine dampens the excitatory excess of caffeine without cancelling its effect on attention. There is evidence for the individual effects. For the synergy, that is, for the combination achieving more than caffeine alone, the evidence is weak — EFSA examined exactly this claim and did not recognize it.

What the combination measurably does

The reference paper is a systematic review and meta-analysis of randomized controlled trials in healthy participants; of 50 included RCTs, 15 entered at least one meta-analysis. Significant results were accuracy in the digit vigilance test with SMD = 0.20 (0.02 to 0.38) and in the attention switching test with SMD = 0.33 (0.13 to 0.54), each in the second hour after intake.

It is notable which value was not significant: of all things the largest point estimate, choice reaction time in the first hour with SMD = −0.48 (−1.01 to 0.05). Overall mood in the second hour also crosses zero (SMD = 0.26; −0.10 to 0.63). The effects of the combination are thus small to moderate, occur in the first and second hour and are most reliable where accuracy in vigilance and task switching is concerned.

What the authorities say about the add-ons

For citicoline, the claimed mechanism is that it supplies choline as a precursor of acetylcholine. In 2024, EFSA examined a corresponding memory claim and assessed three human studies: only one randomized controlled trial in healthy people showed a favorable effect on episodic memory, in another study it did not occur, and data in dementia patients did not support it either. No convincing mechanism of action had been presented. The panel’s conclusion: a cause-and-effect relationship has not been established. In the one positive study, with 100 healthy people aged between 50 and 85, the reported memory improvements were moreover secondary endpoints.

What is well supported

The foundation is caffeine, and there the situation is clear: EFSA has recognized an effect of black tea on attention, explicitly on the basis of its caffeine content, with the condition of at least 75 mg of caffeine in total within 90 minutes. The safe amounts have also been set by the authorities. The second robust block is L-theanine: across 31 randomized trials with 1,168 participants, an improved choice reaction time with SMD = 0.51, plus, in a separate meta-analysis of 19 papers with 897 participants, better subjective sleep quality (SMD = 0.43), shorter subjective sleep onset latency (0.15) and less daytime impairment (0.33). For the combination itself, the accuracy findings in the second hour after intake have been reproduced: digit vigilance SMD = 0.20, attention switching SMD = 0.33.

What the studies show

Meta-analysis on the combination of L-theanine and caffeine

Systematic review and meta-analysis of randomized controlled trials in healthy participants, search in four databases up to and including August 2023; 50 RCTs in the review, 15 in at least one meta-analysis. Theanine plus caffeine versus placebo: choice reaction time in the first hour SMD = −0.48 (−1.01 to 0.05), accuracy in the digit vigilance test in the second hour SMD = 0.20 (0.02 to 0.38), accuracy in the attention switching test in the second hour SMD = 0.33 (0.13 to 0.54), overall mood in the second hour SMD = 0.26 (−0.10 to 0.63). The authors also found a small to moderate difference in favor of theanine alone versus placebo.

The largest analysis on L-theanine alone

Systematic review and meta-analysis of 31 randomized controlled trials with n = 1,168, oral L-theanine versus placebo in healthy and clinical populations. The primary endpoint was the acute effect of a single dose on stress in healthy adults. Choice reaction time improved robustly: SMD = 0.51 (0.25 to 0.77). The acute stress reduction, by contrast, was modest (SMD = 0.31) and, according to the authors, was driven largely by studies with a high risk of bias. There was no significant effect on fatigue, and effects on anxiety were inconsistent. The safety analysis of dropout rates and reasons for dropout found no serious adverse events.

What the studies do not show

The claimed synergy of caffeine and L-theanine was explicitly not recognized by EFSA: the applicant argued on the basis of the interaction of the two substances, and the panel wrote that the observed effect could be explained by the caffeine content alone. This is the strongest single objection to the stack logic. In addition, the largest pooled effect of the combination is not significant — choice reaction time in the first hour, SMD = −0.48 with an interval from −1.01 to 0.05 — and neither is overall mood. The frequently cited stress-reducing effect of L-theanine is modest (SMD = 0.31) and, according to the authors, driven largely by studies with a high risk of bias. Nor has the widespread mixing ratio of 1 to 2 been studied as an effective factor in any of the meta-analyses reviewed; the effect was not broken down by ratio.

For the add-ons, it gets thinner. For citicoline, the memory effect has been classified by the authorities as not established, along with a missing mechanism. For alpha-GPC in healthy young adults there is no meta-analysis; the available human studies in healthy people are acute and small, and the larger clinical literature concerns cognitive disorders and dementia. For lion’s mane, human data on the effect on BDNF are completely missing, and in healthy people the picture is contradictory: an acute study with 18 participants without a significant effect, a 28-day study with 41 participants with a trend in subjective stress. And the stack as a whole has never been studied. There is no study that tests all four substances together against a control condition — every statement about the stack is an addition of individual findings, not a measured quantity.

How to do it

What can be read from the papers as a schedule: the effects of the combination occurred in the first and second hour after intake, with the significant findings on vigilance and task switching in the second hour. For L-theanine alone, the tested condition was a single dose 30 to 60 minutes before the cognitive task. For caffeine there are official figures: the attention claim recognized by EFSA is based on at least 75 mg of caffeine in total, drunk within 90 minutes, and the upper limit for healthy adults is 200 mg as a single dose and 400 mg spread over the day.

For the other substances we give no amounts here, because no European authorization or no completed assessment exists for them; the protocols are in the linked papers. What can be said without giving amounts: for lion’s mane, the study with a positive result ran over 16 weeks, and scores fell significantly four weeks after stopping — so the effect was not lasting. For alpha-GPC, EFSA assessed a maximum use level of 203.7 mg per day in food supplements; above this amount there is no safety assessment. And the widespread rule of not stacking daily in order to avoid tolerance is plausible for caffeine and generally described; no data were found on tolerance development to L-theanine, alpha-GPC or lion’s mane.

Safety

For caffeine, the limits have been set by the authorities: at up to 200 mg as a single dose or within a short period, corresponding to 3 mg per kilogram of body weight, no health risk is to be expected for healthy adults; with habitual consumption, up to 400 mg spread over the day is considered safe. For pregnant and breastfeeding women, up to 200 mg spread over the day applies; for children and adolescents, 3 mg per kg of body weight. The caveat that the BfR explicitly records is important: the underlying opinion did not assess possible harmful effects of caffeine for people with illnesses or complaints or for people who also take medicines or drugs. Anyone with cardiac arrhythmias, untreated high blood pressure, an anxiety disorder or a sleep disorder, or who takes medicines metabolized via CYP1A2, should take this question to a doctor. For L-theanine, the safety statement is the most robust of the whole stack: in the meta-analysis of 31 RCTs with 1,168 participants, no serious adverse events were reported when dropout rates and reasons for dropout were analyzed. For alpha-GPC, EFSA saw no safety concerns under the proposed conditions of use; on the concern about atherosclerosis and stroke, one review states that possible risks still need confirmation, while the largest cohort study to date, with 508,107 patients, found no increased risk but rather a lower risk of progression to Alzheimer’s dementia (hazard ratio 0.899) and to vascular dementia (0.832). These are observational data from a population with cognitive impairment and cannot be transferred to healthy people. For citicoline, no separate safety assessment was found in this research. For lion’s mane, the systematic review lists stomach complaints, headaches and allergic reactions as possible side effects, which is relevant in mushroom allergy. None of these substances has been studied in pregnancy, breastfeeding or in children and adolescents, with the exception of the official caffeine amounts; anyone who takes medication regularly, in particular anticoagulants, antidepressants or blood pressure medication, should discuss the combination with the person treating them.

BK-Score Supported, with caveats

Human evidence		6
Mechanism		7
Safety data		8
Hype gap		6
Track record of use		9

The combination of caffeine and L-theanine has been studied in several randomized trials on attention and task switching, with small but repeatedly found effects. This does not apply to lion’s mane – human data are missing there.

The score rates the state of knowledge, not the effect. “Safety data 9” means well studied – not harmless.
Subjective assessment by Biohacking Kompakt based on published scoring rules – not a scientific rating and not a medical recommendation. Rules and all ratings (German)

Frequently asked questions about the nootropics starter stack

Why caffeine and L-theanine together and not caffeine alone?

The common justification is that L-theanine takes away the nervousness of caffeine without taking away the alertness. The individual effects on reaction time, accuracy and mood are measurable in meta-analyses. The synergy itself is not: EFSA examined exactly this claim for black tea and concluded that the observed effect on attention could be explained by the caffeine content alone.

How much caffeine is still safe?

According to the EFSA risk assessment, as summarized by the BfR: for healthy adults up to 200 mg as a single dose or 3 mg per kilogram of body weight, and up to 400 mg spread over the day. For pregnant and breastfeeding women up to 200 mg per day, for children and adolescents 3 mg per kilogram of body weight. Important: the assessment applies to healthy people not taking medication. For people with illnesses and for interactions with medicines, EFSA explicitly made no statement.

How quickly does the combination work, and for how long?

In the meta-analysis, the differences from placebo appeared in the first and second hour after intake, with the statistically significant findings on accuracy in vigilance and task switching in the second hour. For L-theanine alone, the tested condition was a single dose 30 to 60 minutes before the task. These papers say nothing about the duration of the effect beyond that.

Do alpha-GPC or citicoline add anything?

For citicoline, EFSA examined in 2024 whether a memory effect is established and concluded that it is not. Of three human studies submitted, only one showed an effect, and the panel did not consider a plausible mechanism to have been demonstrated. For alpha-GPC in healthy people there is no meta-analysis; the available studies are acute and small. EFSA’s assessment of alpha-GPC concerns safety only, not benefit.

Is it true that lion’s mane stimulates nerve growth factor?

This has been shown in cells, specifically in human astrocytoma cells in culture, and in animal models. A measurement of NGF or BDNF in humans after intake could not be found in the research. The only human study with a clearly positive result was in people with mild cognitive impairment over 16 weeks, and the effect fell again after stopping. In healthy people, two small studies found an acute Stroop effect and nothing at all, respectively.

Can I simply take the whole stack?

It has not been studied; there is not a single study on this combination. What exists are findings on caffeine, which is well supported and has been assessed by the authorities, on L-theanine with several meta-analyses and small effects, on citicoline with a memory claim rejected by EFSA, on alpha-GPC with assessed safety and unproven benefit in healthy people, and on lion’s mane with one positive study in people with cognitive impairment and thin evidence in healthy people.

In depthAlpha-GPC
In depthCiticoline (CDP-choline)
In depthL-theanine
Same category: Stress & mindMeditation 10 min daily
Same category: Stress & mindGratitude journaling
Same category: Stress & mindNo phone in the first hour

Sources

Open in the database – with all tips, filters and BK-Score (German app)

Information only, not medical advice and not a usage recommendation. If you have pre-existing conditions, and before making major changes, consult a doctor. Last updated: 2026-09-13.